Biosense Webster, Inc.

This study is testing a new system (VARIPULSE catheter and TRUPULSE generator) with updated software to treat atrial fibrillation, a condition where the heart beats irregularly. About 50 adults with either short-lasting (paroxysmal) or longer-lasting (persistent) atrial fibrillat…

This study compares a new catheter (VARIPULSE) to an approved one (FARAWAVE) for treating persistent atrial fibrillation, a condition where the heart beats irregularly for over a week. About 466 adults with this condition will be randomly assigned to one of the two procedures. Th…

This study tests a new device that uses quick electric pulses to fix faulty heart signals in people with a type of irregular heartbeat called paroxysmal atrial fibrillation. About 440 adults who have not gotten relief from medication will receive the procedure. The goal is to see…

This study looks at the long-term safety and effectiveness of the VARIPULSE catheter, a device already approved by the FDA, for treating people with a type of irregular heartbeat called paroxysmal atrial fibrillation. About 276 participants will undergo a procedure to isolate the…

This study is following 8,000 people with heart rhythm problems who are getting a standard procedure called catheter ablation. The goal is to check how safe and effective the approved devices are in everyday use. Researchers will track complications and how well the procedure wor…

This study is testing a new paddle-shaped catheter designed to map abnormal heart rhythms (arrhythmias) in the upper and lower chambers of the heart. About 60 people with conditions like atrial fibrillation or ventricular tachycardia will take part. The main goal is to check if t…